Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Long-term Consumption of 2-O-?-D-Glucopyranosyl-L-ascorbic Acid from the Fruits of Lycium barbarum Modulates Gut Microbiota in C57BL/6 Micee. β
Go to Publication β
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: Issue Pages: Pub: 2020 Jul 24 Epub: 2020 Jul 24 Authors Dong W , Huang K , Yan Y , Wan P , Peng Y , Zeng X , Cao Y , |
|
|
Goji berry leaf exerts a comparable effect against colitis and microbiota dysbiosis to its fruit in dextran-sulfate-sodium-treated mice. β
Go to Publication β
Food & function (Food Funct ) Vol: 14 Issue 7 Pages: 3026-3037 Pub: 2023 Apr 3 Epub: 2023 Apr 3 Authors Yu C , Chen Y , Ahmadi S , Wu D , Wu J , Ding T , Liu D , Ye X , Chen S , Pan H , |
|
|
Lycium barbarum polysaccharide alleviates DSS-induced chronic ulcerative colitis by restoring intestinal barrier function and modulating gut microbiota. β
Go to Publication β
Annals of medicine (Ann Med ) Vol: 55 Issue 2 Pages: 2290213 Pub: 2023 Epub: 2023 Dec 7 Authors Li ZY , Lin LH , Liang HJ , Li YQ , Zhao FQ , Sun TY , Liu ZY , Zhu JY , Gu F , Xu JN , Hao QY , Zhou DS , Zhai HH , |
|
|
Lycium barbarum polysaccharide remodels colon inflammatory microenvironment and improves gut health. β
Go to Publication β
Heliyon (Heliyon ) Vol: 10 Issue 10 Pages: e30594 Pub: 2024 May 30 Epub: 2024 May 9 Authors Li R , Yang P , Liu B , Ye Z , Zhang P , Li M , Gong Y , Huang Y , Yang L , Li M , |
|
|
Lycium barbarum polysaccharide remodels colon inflammatory microenvironment and improves gut health. β
Go to Publication β
Heliyon (Heliyon ) Vol: 10 Issue 10 Pages: e30594 Pub: 2024 May 30 Epub: 2024 May 9 Authors Li R , Yang P , Liu B , Ye Z , Zhang P , Li M , Gong Y , Huang Y , Yang L , Li M , |
|
|
Lycium barbarum Polysaccharide Regulates the Lipid Metabolism and Alters Gut Microbiota in High-Fat Diet Induced Obese Mice. β
Go to Publication β
International journal of environmental research and public health (Int J Environ Res Public Health ) Vol: 19 Issue 19 Pages: Pub: 2022 Sep 24 Epub: 2022 Sep 24 Authors Xia H , Zhou B , Sui J , Ma W , Wang S , Yang L , Sun G , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
